Pharma Clinical Innovation USA
A two-day meeting for clinical leaders focused on predictive data, inclusive trials and the operational use of AI in drug development.
Visit official website
What you need to know
Pharma Clinical Innovation USA brings senior clinical-development leaders together for two days focused on making trials smarter, faster and more scalable. The programme addresses the operational gap between promising pilots and approaches that can work across an entire portfolio.
The official agenda highlights trial design and feasibility, community-led recruitment, AI-enabled delivery and agile evidence generation. Organisers list more than 45 speakers and 25 sessions, with a strong emphasis on director-level and executive participation.
What to expect
- Smarter trial design and feasibility
- Community-led recruitment and patient engagement
- AI, predictive analytics and risk detection
- Agile evidence generation across clinical portfolios
Who should attend
- Clinical operations and development leaders
- R&D and medical-affairs executives
- Patient-engagement and population-science teams
- Technology and data partners serving clinical trials
Clinical innovation becomes valuable when better models produce stronger evidence and more representative trials. This forum is built around that transition from pilot projects to repeatable operations.